Quick Takeaways
- ALEC - Alector, Inc. has 22 insiders with reported activity on this page.
- Net insider value flow over the last year: -$898,846.
- Recent transaction rows are available for direct filing-level review.
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Net insider flow leans to selling over the last 12 months. Net value: -$898,846.
$0
Shares: 0
Insiders: 0
$898,846
Shares: 530,371
Insiders: 7
-$898,846
Shares: -530,371
Insiders: -7
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 129,850 | $0 | $278,596 | -$278,596 |
| 3-6 | 0 | 196,104 | $0 | $219,987 | -$219,987 |
| 6-9 | 0 | 110,952 | $0 | $275,068 | -$275,068 |
| 9-12 | 0 | 93,465 | $0 | $125,195 | -$125,195 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. | 10%+ Owner | $68,200,238 | Mixed | 29 May 2024 | ||
| Terrance McGuire | Director, 10%+ Owner | $60,653,001 | Mixed | 11 Sep 2023 | ||
| Tillman U. Gerngross | Director | $14,702,414 | Mixed | 14 Jun 2023 | ||
| Arnon Rosenthal | Chief Executive Officer, Director | $6,089,567 | -$489,102 | -7.4% | Mixed | 13 Mar 2026 |
| Robert King | Chief Development Officer | $3,062,843 | Mixed | 01 Oct 2022 | ||
| Robert Paul | Chief Medical Officer | $1,302,814 | Mixed | 09 Aug 2021 | ||
| Neil Lindsay Berkley | CFO & Chief Business Officer | $782,549 | -$144,225 | -16% | Mixed | 13 Mar 2026 |
| Shehnaaz Suliman | President and COO | $570,445 | Mixed | 10 Dec 2021 | ||
| Sara Kenkare-Mitra | President and Head of R&D | $561,649 | -$137,666 | -20% | Filing P/S | 03 Dec 2025 |
| David M. Wehner | Director | $553,434 | Mixed | 12 Jun 2024 | ||
| Gary Romano | Chief Medical Officer | $488,610 | Filing P/S | 03 Mar 2025 | ||
| Calvin Yu | Vice President, Finance | $426,374 | Mixed | 02 Jul 2021 | ||
| Marc Grasso | Chief Financial Officer | $396,262 | -$22,068 | -5.3% | Filing P/S | 02 Jun 2025 |
| Grace Wong-Sarad | Principal Accounting Officer | $277,309 | -$71,346 | -20% | Filing P/S | 16 Apr 2026 |
| Paula Hammond | Director | $176,560 | -$32,998 | -16% | Filing P/S | 26 Aug 2025 |
| Kristine Yaffe | Director | $137,388 | -$1,440 | -1% | Filing P/S | 20 Jun 2025 |
| Louis J. Lavigne Jr. | Director | $127,554 | Mixed | 11 Jun 2025 | ||
| Richard H. Scheller | Director | $110,624 | Mixed | 11 Jun 2025 | ||
| Elizabeth A. Garofalo | Director | $104,342 | Mixed | 11 Jun 2025 | ||
| Mark Altmeyer | Director | $81,142 | Mixed | 11 Jun 2025 | ||
| Errol B. Desouza | Director | $81,142 | Mixed | 11 Jun 2025 | ||
| Linda M. Rubinstein | Interim Chief Financial Ofcr | Mixed | 08 Sep 2021 |
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Polaris Venture Management Co. VI, L.L.C. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
9,853,817
|
$68,200,238 | — | 29 May 2024 | |
| Terrance McGuire |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,908,813
|
$60,653,001 | — | 11 Sep 2023 | |
| TCG Crossover GP II, LLC |
13D/G
|
Chen Yu |
9.2%
|
10,000,000
|
$29,600,000 | $0 | 22 Oct 2025 | |
| Polaris Venture Partners VI, L.P. |
13D/G
|
Terrance G. McGuire |
6.5%
|
7,095,251
|
$21,001,943 | $0 | 30 Sep 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
9%
|
10,000,000
|
$15,600,000 | — | 31 Dec 2025 | |
| Tillman U. Gerngross |
3/4/5
|
Director |
—
mixed-class rows
|
2,656,679
mixed-class rows
|
$14,702,414 | — | 14 Jun 2023 | |
| Arnon Rosenthal |
13D/G
3/4/5
|
Chief Executive Officer, Director |
7.4%
|
8,213,925
|
$12,813,723 | $0 | 31 Dec 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
5.2%
|
5,784,214
|
$12,436,060 | +$1,299,479 | 31 Mar 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.2%
|
6,908,054
|
$10,776,564 | — | 31 Dec 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.6%
|
3,599,820
|
$10,655,467 | $0 | 31 Oct 2025 | |
| Foresite Capital Management IV, LLC |
13F
|
Company |
3.5%
|
3,887,200
|
$6,064,032 | — | 31 Dec 2025 | |
| Merck & Co., Inc. |
13F
|
Company |
3.2%
|
3,545,719
|
$5,531,322 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.1%
|
3,442,449
|
$5,362,000 | — | 31 Dec 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
3%
|
3,350,000
|
$5,226,000 | — | 31 Dec 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
2.9%
|
3,265,575
|
$5,094,297 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.1%
|
2,365,151
|
$3,689,636 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2%
|
2,173,202
|
$3,390,195 | — | 31 Dec 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.9%
|
2,082,606
|
$3,248,866 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
2,075,220
|
$3,238,029 | — | 31 Dec 2025 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.8%
|
2,000,000
|
$3,120,000 | — | 31 Dec 2025 | |
| Robert King |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
565,255
mixed-class rows
|
$3,062,843 | — | 01 Oct 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,814,298
|
$2,830,305 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
1,543,650
|
$2,408,094 | — | 31 Dec 2025 | |
| MEDICI CAPITAL LLC |
13F
|
Company |
1.3%
|
1,500,520
|
$2,340,811 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,332,914
|
$2,079,346 | — | 31 Dec 2025 | |
| Euclidean Capital LLC |
13F
|
Company |
1.2%
|
1,307,858
|
$2,040,258 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1%
|
1,166,817
|
$1,820,234 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
|
Company |
1%
|
1,117,986
|
$1,744,058 | — | 31 Dec 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1%
|
1,108,000
|
$1,728,480 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.95%
|
1,055,192
|
$1,646,100 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.93%
|
1,039,656
|
$1,621,863 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.93%
|
1,035,154
|
$1,614,840 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.9%
|
1,006,163
|
$1,569,614 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.89%
|
993,913
|
$1,550,504 | — | 31 Dec 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.82%
|
908,351
|
$1,417,028 | — | 31 Dec 2025 | |
| Elmind Capital, LP |
13F
|
Company |
0.81%
|
900,000
|
$1,404,000 | — | 31 Dec 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.76%
|
850,298
|
$1,326,465 | — | 31 Dec 2025 | |
| Robert Paul |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
318,769
mixed-class rows
|
$1,302,814 | — | 09 Aug 2021 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.68%
|
755,000
|
$1,177,800 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
665,491
|
$1,038,166 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.59%
|
651,800
|
$1,016,808 | — | 31 Dec 2025 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.59%
|
660,168
|
$1,001,481 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.54%
|
599,569
|
$935,327 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.53%
|
592,839
|
$924,829 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
587,653
|
$916,738 | — | 31 Dec 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
559,726
|
$873,173 | — | 31 Dec 2025 | |
| Neil Lindsay Berkley |
3/4/5
|
CFO & Chief Business Officer |
—
mixed-class rows
|
594,260
mixed-class rows
|
$782,549 | -$144,225 | 13 Mar 2026 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
437,959
|
$683,217 | — | 31 Dec 2025 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.09%
|
100,000
|
$661,000 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.36%
|
398,687
|
$621,952 | — | 31 Dec 2025 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -1.71% | $4,823 | $2.65 | -1,820 | 104,645 | 16 Apr 2026 | Direct |
| Neil Lindsay Berkley | ALEC | Common Stock | Award | 15.8% | 54,600 | 399,260 | 15 Mar 2026 | Direct | ||
| Arnon Rosenthal | ALEC | Common Stock | Award | 4.97% | 116,246 | 2,454,422 | 13 Mar 2026 | Direct | ||
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -0.93% | $2,650 | $2.65 | -1,000 | 106,465 | 10 Mar 2026 | Direct |
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -3.04% | $7,012 | $2.08 | -3,367 | 107,465 | 03 Mar 2026 | Direct |
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -6.79% | $17,138 | $2.12 | -8,071 | 110,832 | 02 Mar 2026 | Direct |
| Arnon Rosenthal | ALEC | Common Stock | Sale | -3.38% | $173,822 | $2.12 | -81,864 | 2,338,176 | 02 Mar 2026 | Direct |
| Neil Lindsay Berkley | ALEC | Common Stock | Sale | -7.92% | $62,954 | $2.12 | -29,649 | 344,660 | 02 Mar 2026 | Direct |
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -3.32% | $10,198 | $2.50 | -4,079 | 118,903 | 26 Feb 2026 | Direct |
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -3.72% | $5,751 | $1.21 | -4,753 | 122,982 | 05 Dec 2025 | Direct |
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -5.93% | $9,019 | $1.12 | -8,056 | 127,735 | 03 Dec 2025 | Direct |
| Arnon Rosenthal | ALEC | Common Stock | Sale | -4.13% | $116,827 | $1.12 | -104,347 | 2,420,040 | 03 Dec 2025 | Direct |
| Sara Kenkare-Mitra | ALEC | Common Stock | Sale | -7.67% | $46,673 | $1.12 | -41,687 | 501,652 | 03 Dec 2025 | Direct |
| Neil Lindsay Berkley | ALEC | Common Stock | Sale | -9.05% | $41,717 | $1.12 | -37,261 | 374,309 | 03 Dec 2025 | Direct |
| Neil Lindsay Berkley | ALEC | Common Stock | Award | 18.8% | 65,000 | 411,570 | 10 Nov 2025 | Direct | ||
| Neil Lindsay Berkley | ALEC | Employee Stock Option (right to buy) | Award | 195,000 | 195,000 | 10 Nov 2025 | Direct | |||
| Grace Wong-Sarad | ALEC | Common Stock | Award | 31.3% | 32,343 | 135,791 | 10 Nov 2025 | Direct | ||
| Grace Wong-Sarad | ALEC | Employee Stock Option (right to buy) | Award | 48,535 | 48,535 | 10 Nov 2025 | Direct | |||
| Arnon Rosenthal | ALEC | Common Stock | Award | 7.41% | 174,167 | 2,524,387 | 10 Nov 2025 | Direct | ||
| Arnon Rosenthal | ALEC | Employee Stock Option (right to buy) | Award | 522,500 | 522,500 | 10 Nov 2025 | Direct | |||
| Grace Wong-Sarad | ALEC | Common Stock | Sale | -5.4% | $14,756 | $2.50 | -5,910 | 103,448 | 02 Sep 2025 | Direct |
| Neil Lindsay Berkley | ALEC | Common Stock | Sale | -4.37% | $39,554 | $2.50 | -15,842 | 346,570 | 02 Sep 2025 | Direct |
| Sara Kenkare-Mitra | ALEC | Common Stock | Sale | -4.17% | $59,019 | $2.50 | -23,638 | 543,339 | 02 Sep 2025 | Direct |
| Arnon Rosenthal | ALEC | Common Stock | Sale | -2.15% | $128,740 | $2.50 | -51,562 | 2,350,220 | 02 Sep 2025 | Direct |
| Paula Hammond | ALEC | Common Stock | Sale | -15.8% | $32,998 | $2.36 | -14,000 | 74,909 | 26 Aug 2025 | Direct |
| Neil Lindsay Berkley | ALEC | Employee Stock Option (right to buy) | Award | 18,000 | 18,000 | 01 Jul 2025 | Direct | |||
| Sara Kenkare-Mitra | ALEC | Common Stock | Award | 10.7% | 54,725 | 566,977 | 01 Jul 2025 | Direct | ||
| Sara Kenkare-Mitra | ALEC | Employee Stock Option (right to buy) | Award | 18,250 | 18,250 | 01 Jul 2025 | Direct | |||
| Arnon Rosenthal | ALEC | Common Stock | Award | 5.68% | 137,125 | 2,551,782 | 01 Jul 2025 | Direct | ||
| Arnon Rosenthal | ALEC | Employee Stock Option (right to buy) | Award | 45,700 | 45,700 | 01 Jul 2025 | Direct | |||
| Kristine Yaffe | ALEC | Common Stock | Sale | -1.04% | $1,440 | $1.44 | -1,000 | 95,409 | 20 Jun 2025 | Direct |
| Paula Hammond | ALEC | Common Stock | Award | 47.7% | 28,700 | 88,909 | 11 Jun 2025 | Direct | ||
| Paula Hammond | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Kristine Yaffe | ALEC | Common Stock | Award | 42.4% | 28,700 | 96,409 | 11 Jun 2025 | Direct | ||
| Kristine Yaffe | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Elizabeth A. Garofalo | ALEC | Common Stock | Award | 46.9% | 28,700 | 89,950 | 11 Jun 2025 | Direct | ||
| Elizabeth A. Garofalo | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Richard H. Scheller | ALEC | Common Stock | Award | 43% | 28,700 | 95,366 | 11 Jun 2025 | Direct | ||
| Richard H. Scheller | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Louis J. Lavigne Jr. | ALEC | Common Stock | Award | 40.6% | 28,700 | 99,409 | 11 Jun 2025 | Direct | ||
| Louis J. Lavigne Jr. | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Errol B. Desouza | ALEC | Common Stock | Award | 69.6% | 28,700 | 69,950 | 11 Jun 2025 | Direct | ||
| Errol B. Desouza | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Mark Altmeyer | ALEC | Common Stock | Award | 69.6% | 28,700 | 69,950 | 11 Jun 2025 | Direct | ||
| Mark Altmeyer | ALEC | Stock Option (right to buy) | Award | 9,450 | 9,450 | 11 Jun 2025 | Direct | |||
| Marc Grasso | ALEC | Common Stock | Sale | -5.28% | $22,068 | $1.34 | -16,488 | 296,072 | 02 Jun 2025 | Direct |
| Sara Kenkare-Mitra | ALEC | Common Stock | Sale | -4.46% | $31,974 | $1.34 | -23,890 | 512,252 | 02 Jun 2025 | Direct |
| Arnon Rosenthal | ALEC | Common Stock | Sale | -2.11% | $69,713 | $1.34 | -52,087 | 2,414,657 | 02 Jun 2025 | Direct |
| Richard H. Scheller | ALEC | Common Stock | Award | 31.2% | 15,833 | 66,666 | 02 May 2025 | Direct |